|
(S)-4-AHCP
|
S611164-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(S)-4-AHCP
|
S611164-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(S)-23
|
S611163-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(S)-23
|
S611163-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1S,2S,5R,7R,10R,11S,15R,16S)-5-hydroxy-14-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-16-yl (2S)-2-methylbutanoate
|
S609498-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1S,2S,5R,7R,10R,11S,15R,16S)-5-hydroxy-14-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-16-yl (2S)-2-methylbutanoate
|
S609498-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,3R)-3-amino-2-hydroxy-N-(3-methylbutyl)-4-phenylbutanamide
|
S609487-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,3R)-3-amino-2-hydroxy-N-(3-methylbutyl)-4-phenylbutanamide
|
S609487-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S)-2-[6-[(2,4-diaminopteridin-6-yl)methylamino]-3-oxo-1H-isoindol-2-yl]pentanedioic acid
|
S609486-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S)-2-[6-[(2,4-diaminopteridin-6-yl)methylamino]-3-oxo-1H-isoindol-2-yl]pentanedioic acid
|
S609486-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S)-2-[[(2S)-1-hydroxy-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamoylamino]pentanedioic acid
|
S609453-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S)-2-[[(2S)-1-hydroxy-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamoylamino]pentanedioic acid
|
S609453-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3S)-3-[[2-(2-fluorophenyl)-3-oxo-1H-pyrazole-5-carbonyl]amino]-3-(2-methylphenyl)propanoic acid
|
S609444-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3S)-3-[[2-(2-fluorophenyl)-3-oxo-1H-pyrazole-5-carbonyl]amino]-3-(2-methylphenyl)propanoic acid
|
S609444-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one
|
S609443-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one
|
S609443-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(S)-3-Methyl-4-(7-((R)-3-methylmorpholino)-2-(1H-pyrazol-3-yl)thiazolo[5,4-d]pyrimidin-5-yl)morpholine
|
S609431-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(S)-3-Methyl-4-(7-((R)-3-methylmorpholino)-2-(1H-pyrazol-3-yl)thiazolo[5,4-d]pyrimidin-5-yl)morpholine
|
S609431-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((1S,3R)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate
|
S609430-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((1S,3R)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate
|
S609430-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-[(3R,5S)-3-amino-5-(trifluoromethyl)piperidin-1-yl]quinoline-8-carbonitrile
|
S609400-5mg
|
Moligand™ |
2101938-42-3 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-[(3R,5S)-3-amino-5-(trifluoromethyl)piperidin-1-yl]quinoline-8-carbonitrile
|
S609400-25mg
|
Moligand™ |
2101938-42-3 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[(3S)-3-[[(2S)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]-4-methylpentanoyl]amino]-2-oxo-4-[(3S)-2-oxopiperidin-3-yl]butyl] 2,6-bis(trifluoromethyl)benzoate
|
S609396-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[(3S)-3-[[(2S)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]-4-methylpentanoyl]amino]-2-oxo-4-[(3S)-2-oxopiperidin-3-yl]butyl] 2,6-bis(trifluoromethyl)benzoate
|
S609396-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |